- Sottometti
- Personalizza
- Aiuto
- de
- en
- fr
- it
- ospite :: login
Heterogeneity in outcomes of treated HIV-positive patients in Europe and North America: relation with patient and cohort characteristics
May, Margaret T. ; Hogg, Robert S. ; Justice, Amy C. ; Shepherd, Bryan E. ; Costagliola, Dominique ; Ledergerber, Bruno ; Thiébaut, Rodolphe ; Gill, M John ; Kirk, Ole ; van Sighem, Ard ; Saag, Michael S. ; Navarro, Gemma ; Sobrino-Vegas, Paz ; Lampe, Fiona ; Ingle, Suzanne ; Guest, Jodie L. ; Crane, Heidi M. ; D'Arminio Monforte, Antonella ; Vehreschild, Jörg J. ; Sterne, Jonathan AC
In: International Journal of Epidemiology, 2012, vol. 41, no. 6, p. 1807-1820
Aggiungi alla tua listaLinks
Esporta come
- Titre
-
- Heterogeneity in outcomes of treated HIV-positive patients in Europe and North America: relation with patient and cohort characteristics
- Auteur
-
- May, Margaret T.. School of Social and Community Medicine, University of Bristol, Bristol, UK, 2Division of Epidemiology and Population Health, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada, 3Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada, 4Center for Interdisciplinary Research on AIDS, Yale University School of Medicine, New Haven, CT, USA, 5VA Connecticut Healthcare System, West Haven, CT, USA, 6Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, TN, USA, 7INSERM, U943, F-75013 Paris, France, 8UPMC University Paris 06, UMR S943, F-75013 Paris, France, 9AP-HP, Groupe hospitalier Pitié-Salpêtrière, Service de Maladies Infectieuses et Tropicales, F-75013 Paris, France, 10Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Switzerland, 11University Bordeaux, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, F-33000 Bordeaux, France, 12INSERM, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, F-33000 Bordeaux, France, 13Division of Infectious Diseases, University of Calgary, Calgary, Canada, 14Copenhagen HIV Programme, Panum Institute, University of Copenhagen, Denmark, 15Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark, 16Stichting HIV Monitoring, Amsterdam, The Netherlands, 17Division of Infectious Disease, Department of Medicine, University of Alabama, Birmingham, AL, USA, 18Infectious Diseases Program, Corporació Sanitària Parc Taulí, Sabadell, Barcelona, Spain, 19Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid, Spain, 20Research Department of Infection and Population Health, UCL Medical School, London, UK, 21HIV Atlanta VA Cohort Study (HAVACS), Atlanta Veterans Affairs Medical Center, Decatur, GA, USA, 22University of Washington School of Medicine, Seattle, WA, USA, 23Clinic of Infectious Diseases and Tropical Medicine, San Paolo Hospital, University of Milan, Italy and 24First Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany
- Hogg, Robert S.. School of Social and Community Medicine, University of Bristol, Bristol, UK, 2Division of Epidemiology and Population Health, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada, 3Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada, 4Center for Interdisciplinary Research on AIDS, Yale University School of Medicine, New Haven, CT, USA, 5VA Connecticut Healthcare System, West Haven, CT, USA, 6Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, TN, USA, 7INSERM, U943, F-75013 Paris, France, 8UPMC University Paris 06, UMR S943, F-75013 Paris, France, 9AP-HP, Groupe hospitalier Pitié-Salpêtrière, Service de Maladies Infectieuses et Tropicales, F-75013 Paris, France, 10Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Switzerland, 11University Bordeaux, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, F-33000 Bordeaux, France, 12INSERM, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, F-33000 Bordeaux, France, 13Division of Infectious Diseases, University of Calgary, Calgary, Canada, 14Copenhagen HIV Programme, Panum Institute, University of Copenhagen, Denmark, 15Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark, 16Stichting HIV Monitoring, Amsterdam, The Netherlands, 17Division of Infectious Disease, Department of Medicine, University of Alabama, Birmingham, AL, USA, 18Infectious Diseases Program, Corporació Sanitària Parc Taulí, Sabadell, Barcelona, Spain, 19Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid, Spain, 20Research Department of Infection and Population Health, UCL Medical School, London, UK, 21HIV Atlanta VA Cohort Study (HAVACS), Atlanta Veterans Affairs Medical Center, Decatur, GA, USA, 22University of Washington School of Medicine, Seattle, WA, USA, 23Clinic of Infectious Diseases and Tropical Medicine, San Paolo Hospital, University of Milan, Italy and 24First Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany
- Justice, Amy C.. School of Social and Community Medicine, University of Bristol, Bristol, UK, 2Division of Epidemiology and Population Health, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada, 3Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada, 4Center for Interdisciplinary Research on AIDS, Yale University School of Medicine, New Haven, CT, USA, 5VA Connecticut Healthcare System, West Haven, CT, USA, 6Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, TN, USA, 7INSERM, U943, F-75013 Paris, France, 8UPMC University Paris 06, UMR S943, F-75013 Paris, France, 9AP-HP, Groupe hospitalier Pitié-Salpêtrière, Service de Maladies Infectieuses et Tropicales, F-75013 Paris, France, 10Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Switzerland, 11University Bordeaux, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, F-33000 Bordeaux, France, 12INSERM, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, F-33000 Bordeaux, France, 13Division of Infectious Diseases, University of Calgary, Calgary, Canada, 14Copenhagen HIV Programme, Panum Institute, University of Copenhagen, Denmark, 15Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark, 16Stichting HIV Monitoring, Amsterdam, The Netherlands, 17Division of Infectious Disease, Department of Medicine, University of Alabama, Birmingham, AL, USA, 18Infectious Diseases Program, Corporació Sanitària Parc Taulí, Sabadell, Barcelona, Spain, 19Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid, Spain, 20Research Department of Infection and Population Health, UCL Medical School, London, UK, 21HIV Atlanta VA Cohort Study (HAVACS), Atlanta Veterans Affairs Medical Center, Decatur, GA, USA, 22University of Washington School of Medicine, Seattle, WA, USA, 23Clinic of Infectious Diseases and Tropical Medicine, San Paolo Hospital, University of Milan, Italy and 24First Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany
- Shepherd, Bryan E.. School of Social and Community Medicine, University of Bristol, Bristol, UK, 2Division of Epidemiology and Population Health, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada, 3Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada, 4Center for Interdisciplinary Research on AIDS, Yale University School of Medicine, New Haven, CT, USA, 5VA Connecticut Healthcare System, West Haven, CT, USA, 6Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, TN, USA, 7INSERM, U943, F-75013 Paris, France, 8UPMC University Paris 06, UMR S943, F-75013 Paris, France, 9AP-HP, Groupe hospitalier Pitié-Salpêtrière, Service de Maladies Infectieuses et Tropicales, F-75013 Paris, France, 10Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Switzerland, 11University Bordeaux, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, F-33000 Bordeaux, France, 12INSERM, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, F-33000 Bordeaux, France, 13Division of Infectious Diseases, University of Calgary, Calgary, Canada, 14Copenhagen HIV Programme, Panum Institute, University of Copenhagen, Denmark, 15Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark, 16Stichting HIV Monitoring, Amsterdam, The Netherlands, 17Division of Infectious Disease, Department of Medicine, University of Alabama, Birmingham, AL, USA, 18Infectious Diseases Program, Corporació Sanitària Parc Taulí, Sabadell, Barcelona, Spain, 19Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid, Spain, 20Research Department of Infection and Population Health, UCL Medical School, London, UK, 21HIV Atlanta VA Cohort Study (HAVACS), Atlanta Veterans Affairs Medical Center, Decatur, GA, USA, 22University of Washington School of Medicine, Seattle, WA, USA, 23Clinic of Infectious Diseases and Tropical Medicine, San Paolo Hospital, University of Milan, Italy and 24First Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany
- Costagliola, Dominique. School of Social and Community Medicine, University of Bristol, Bristol, UK, 2Division of Epidemiology and Population Health, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada, 3Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada, 4Center for Interdisciplinary Research on AIDS, Yale University School of Medicine, New Haven, CT, USA, 5VA Connecticut Healthcare System, West Haven, CT, USA, 6Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, TN, USA, 7INSERM, U943, F-75013 Paris, France, 8UPMC University Paris 06, UMR S943, F-75013 Paris, France, 9AP-HP, Groupe hospitalier Pitié-Salpêtrière, Service de Maladies Infectieuses et Tropicales, F-75013 Paris, France, 10Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Switzerland, 11University Bordeaux, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, F-33000 Bordeaux, France, 12INSERM, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, F-33000 Bordeaux, France, 13Division of Infectious Diseases, University of Calgary, Calgary, Canada, 14Copenhagen HIV Programme, Panum Institute, University of Copenhagen, Denmark, 15Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark, 16Stichting HIV Monitoring, Amsterdam, The Netherlands, 17Division of Infectious Disease, Department of Medicine, University of Alabama, Birmingham, AL, USA, 18Infectious Diseases Program, Corporació Sanitària Parc Taulí, Sabadell, Barcelona, Spain, 19Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid, Spain, 20Research Department of Infection and Population Health, UCL Medical School, London, UK, 21HIV Atlanta VA Cohort Study (HAVACS), Atlanta Veterans Affairs Medical Center, Decatur, GA, USA, 22University of Washington School of Medicine, Seattle, WA, USA, 23Clinic of Infectious Diseases and Tropical Medicine, San Paolo Hospital, University of Milan, Italy and 24First Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany
- Ledergerber, Bruno. School of Social and Community Medicine, University of Bristol, Bristol, UK, 2Division of Epidemiology and Population Health, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada, 3Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada, 4Center for Interdisciplinary Research on AIDS, Yale University School of Medicine, New Haven, CT, USA, 5VA Connecticut Healthcare System, West Haven, CT, USA, 6Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, TN, USA, 7INSERM, U943, F-75013 Paris, France, 8UPMC University Paris 06, UMR S943, F-75013 Paris, France, 9AP-HP, Groupe hospitalier Pitié-Salpêtrière, Service de Maladies Infectieuses et Tropicales, F-75013 Paris, France, 10Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Switzerland, 11University Bordeaux, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, F-33000 Bordeaux, France, 12INSERM, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, F-33000 Bordeaux, France, 13Division of Infectious Diseases, University of Calgary, Calgary, Canada, 14Copenhagen HIV Programme, Panum Institute, University of Copenhagen, Denmark, 15Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark, 16Stichting HIV Monitoring, Amsterdam, The Netherlands, 17Division of Infectious Disease, Department of Medicine, University of Alabama, Birmingham, AL, USA, 18Infectious Diseases Program, Corporació Sanitària Parc Taulí, Sabadell, Barcelona, Spain, 19Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid, Spain, 20Research Department of Infection and Population Health, UCL Medical School, London, UK, 21HIV Atlanta VA Cohort Study (HAVACS), Atlanta Veterans Affairs Medical Center, Decatur, GA, USA, 22University of Washington School of Medicine, Seattle, WA, USA, 23Clinic of Infectious Diseases and Tropical Medicine, San Paolo Hospital, University of Milan, Italy and 24First Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany
- Thiébaut, Rodolphe. School of Social and Community Medicine, University of Bristol, Bristol, UK, 2Division of Epidemiology and Population Health, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada, 3Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada, 4Center for Interdisciplinary Research on AIDS, Yale University School of Medicine, New Haven, CT, USA, 5VA Connecticut Healthcare System, West Haven, CT, USA, 6Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, TN, USA, 7INSERM, U943, F-75013 Paris, France, 8UPMC University Paris 06, UMR S943, F-75013 Paris, France, 9AP-HP, Groupe hospitalier Pitié-Salpêtrière, Service de Maladies Infectieuses et Tropicales, F-75013 Paris, France, 10Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Switzerland, 11University Bordeaux, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, F-33000 Bordeaux, France, 12INSERM, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, F-33000 Bordeaux, France, 13Division of Infectious Diseases, University of Calgary, Calgary, Canada, 14Copenhagen HIV Programme, Panum Institute, University of Copenhagen, Denmark, 15Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark, 16Stichting HIV Monitoring, Amsterdam, The Netherlands, 17Division of Infectious Disease, Department of Medicine, University of Alabama, Birmingham, AL, USA, 18Infectious Diseases Program, Corporació Sanitària Parc Taulí, Sabadell, Barcelona, Spain, 19Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid, Spain, 20Research Department of Infection and Population Health, UCL Medical School, London, UK, 21HIV Atlanta VA Cohort Study (HAVACS), Atlanta Veterans Affairs Medical Center, Decatur, GA, USA, 22University of Washington School of Medicine, Seattle, WA, USA, 23Clinic of Infectious Diseases and Tropical Medicine, San Paolo Hospital, University of Milan, Italy and 24First Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany
- Gill, M John. School of Social and Community Medicine, University of Bristol, Bristol, UK, 2Division of Epidemiology and Population Health, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada, 3Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada, 4Center for Interdisciplinary Research on AIDS, Yale University School of Medicine, New Haven, CT, USA, 5VA Connecticut Healthcare System, West Haven, CT, USA, 6Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, TN, USA, 7INSERM, U943, F-75013 Paris, France, 8UPMC University Paris 06, UMR S943, F-75013 Paris, France, 9AP-HP, Groupe hospitalier Pitié-Salpêtrière, Service de Maladies Infectieuses et Tropicales, F-75013 Paris, France, 10Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Switzerland, 11University Bordeaux, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, F-33000 Bordeaux, France, 12INSERM, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, F-33000 Bordeaux, France, 13Division of Infectious Diseases, University of Calgary, Calgary, Canada, 14Copenhagen HIV Programme, Panum Institute, University of Copenhagen, Denmark, 15Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark, 16Stichting HIV Monitoring, Amsterdam, The Netherlands, 17Division of Infectious Disease, Department of Medicine, University of Alabama, Birmingham, AL, USA, 18Infectious Diseases Program, Corporació Sanitària Parc Taulí, Sabadell, Barcelona, Spain, 19Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid, Spain, 20Research Department of Infection and Population Health, UCL Medical School, London, UK, 21HIV Atlanta VA Cohort Study (HAVACS), Atlanta Veterans Affairs Medical Center, Decatur, GA, USA, 22University of Washington School of Medicine, Seattle, WA, USA, 23Clinic of Infectious Diseases and Tropical Medicine, San Paolo Hospital, University of Milan, Italy and 24First Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany
- Kirk, Ole. School of Social and Community Medicine, University of Bristol, Bristol, UK, 2Division of Epidemiology and Population Health, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada, 3Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada, 4Center for Interdisciplinary Research on AIDS, Yale University School of Medicine, New Haven, CT, USA, 5VA Connecticut Healthcare System, West Haven, CT, USA, 6Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, TN, USA, 7INSERM, U943, F-75013 Paris, France, 8UPMC University Paris 06, UMR S943, F-75013 Paris, France, 9AP-HP, Groupe hospitalier Pitié-Salpêtrière, Service de Maladies Infectieuses et Tropicales, F-75013 Paris, France, 10Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Switzerland, 11University Bordeaux, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, F-33000 Bordeaux, France, 12INSERM, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, F-33000 Bordeaux, France, 13Division of Infectious Diseases, University of Calgary, Calgary, Canada, 14Copenhagen HIV Programme, Panum Institute, University of Copenhagen, Denmark, 15Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark, 16Stichting HIV Monitoring, Amsterdam, The Netherlands, 17Division of Infectious Disease, Department of Medicine, University of Alabama, Birmingham, AL, USA, 18Infectious Diseases Program, Corporació Sanitària Parc Taulí, Sabadell, Barcelona, Spain, 19Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid, Spain, 20Research Department of Infection and Population Health, UCL Medical School, London, UK, 21HIV Atlanta VA Cohort Study (HAVACS), Atlanta Veterans Affairs Medical Center, Decatur, GA, USA, 22University of Washington School of Medicine, Seattle, WA, USA, 23Clinic of Infectious Diseases and Tropical Medicine, San Paolo Hospital, University of Milan, Italy and 24First Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany
- van Sighem, Ard. School of Social and Community Medicine, University of Bristol, Bristol, UK, 2Division of Epidemiology and Population Health, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada, 3Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada, 4Center for Interdisciplinary Research on AIDS, Yale University School of Medicine, New Haven, CT, USA, 5VA Connecticut Healthcare System, West Haven, CT, USA, 6Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, TN, USA, 7INSERM, U943, F-75013 Paris, France, 8UPMC University Paris 06, UMR S943, F-75013 Paris, France, 9AP-HP, Groupe hospitalier Pitié-Salpêtrière, Service de Maladies Infectieuses et Tropicales, F-75013 Paris, France, 10Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Switzerland, 11University Bordeaux, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, F-33000 Bordeaux, France, 12INSERM, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, F-33000 Bordeaux, France, 13Division of Infectious Diseases, University of Calgary, Calgary, Canada, 14Copenhagen HIV Programme, Panum Institute, University of Copenhagen, Denmark, 15Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark, 16Stichting HIV Monitoring, Amsterdam, The Netherlands, 17Division of Infectious Disease, Department of Medicine, University of Alabama, Birmingham, AL, USA, 18Infectious Diseases Program, Corporació Sanitària Parc Taulí, Sabadell, Barcelona, Spain, 19Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid, Spain, 20Research Department of Infection and Population Health, UCL Medical School, London, UK, 21HIV Atlanta VA Cohort Study (HAVACS), Atlanta Veterans Affairs Medical Center, Decatur, GA, USA, 22University of Washington School of Medicine, Seattle, WA, USA, 23Clinic of Infectious Diseases and Tropical Medicine, San Paolo Hospital, University of Milan, Italy and 24First Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany
- Saag, Michael S.. School of Social and Community Medicine, University of Bristol, Bristol, UK, 2Division of Epidemiology and Population Health, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada, 3Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada, 4Center for Interdisciplinary Research on AIDS, Yale University School of Medicine, New Haven, CT, USA, 5VA Connecticut Healthcare System, West Haven, CT, USA, 6Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, TN, USA, 7INSERM, U943, F-75013 Paris, France, 8UPMC University Paris 06, UMR S943, F-75013 Paris, France, 9AP-HP, Groupe hospitalier Pitié-Salpêtrière, Service de Maladies Infectieuses et Tropicales, F-75013 Paris, France, 10Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Switzerland, 11University Bordeaux, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, F-33000 Bordeaux, France, 12INSERM, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, F-33000 Bordeaux, France, 13Division of Infectious Diseases, University of Calgary, Calgary, Canada, 14Copenhagen HIV Programme, Panum Institute, University of Copenhagen, Denmark, 15Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark, 16Stichting HIV Monitoring, Amsterdam, The Netherlands, 17Division of Infectious Disease, Department of Medicine, University of Alabama, Birmingham, AL, USA, 18Infectious Diseases Program, Corporació Sanitària Parc Taulí, Sabadell, Barcelona, Spain, 19Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid, Spain, 20Research Department of Infection and Population Health, UCL Medical School, London, UK, 21HIV Atlanta VA Cohort Study (HAVACS), Atlanta Veterans Affairs Medical Center, Decatur, GA, USA, 22University of Washington School of Medicine, Seattle, WA, USA, 23Clinic of Infectious Diseases and Tropical Medicine, San Paolo Hospital, University of Milan, Italy and 24First Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany
- Navarro, Gemma. School of Social and Community Medicine, University of Bristol, Bristol, UK, 2Division of Epidemiology and Population Health, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada, 3Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada, 4Center for Interdisciplinary Research on AIDS, Yale University School of Medicine, New Haven, CT, USA, 5VA Connecticut Healthcare System, West Haven, CT, USA, 6Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, TN, USA, 7INSERM, U943, F-75013 Paris, France, 8UPMC University Paris 06, UMR S943, F-75013 Paris, France, 9AP-HP, Groupe hospitalier Pitié-Salpêtrière, Service de Maladies Infectieuses et Tropicales, F-75013 Paris, France, 10Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Switzerland, 11University Bordeaux, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, F-33000 Bordeaux, France, 12INSERM, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, F-33000 Bordeaux, France, 13Division of Infectious Diseases, University of Calgary, Calgary, Canada, 14Copenhagen HIV Programme, Panum Institute, University of Copenhagen, Denmark, 15Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark, 16Stichting HIV Monitoring, Amsterdam, The Netherlands, 17Division of Infectious Disease, Department of Medicine, University of Alabama, Birmingham, AL, USA, 18Infectious Diseases Program, Corporació Sanitària Parc Taulí, Sabadell, Barcelona, Spain, 19Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid, Spain, 20Research Department of Infection and Population Health, UCL Medical School, London, UK, 21HIV Atlanta VA Cohort Study (HAVACS), Atlanta Veterans Affairs Medical Center, Decatur, GA, USA, 22University of Washington School of Medicine, Seattle, WA, USA, 23Clinic of Infectious Diseases and Tropical Medicine, San Paolo Hospital, University of Milan, Italy and 24First Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany
- Sobrino-Vegas, Paz. School of Social and Community Medicine, University of Bristol, Bristol, UK, 2Division of Epidemiology and Population Health, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada, 3Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada, 4Center for Interdisciplinary Research on AIDS, Yale University School of Medicine, New Haven, CT, USA, 5VA Connecticut Healthcare System, West Haven, CT, USA, 6Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, TN, USA, 7INSERM, U943, F-75013 Paris, France, 8UPMC University Paris 06, UMR S943, F-75013 Paris, France, 9AP-HP, Groupe hospitalier Pitié-Salpêtrière, Service de Maladies Infectieuses et Tropicales, F-75013 Paris, France, 10Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Switzerland, 11University Bordeaux, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, F-33000 Bordeaux, France, 12INSERM, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, F-33000 Bordeaux, France, 13Division of Infectious Diseases, University of Calgary, Calgary, Canada, 14Copenhagen HIV Programme, Panum Institute, University of Copenhagen, Denmark, 15Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark, 16Stichting HIV Monitoring, Amsterdam, The Netherlands, 17Division of Infectious Disease, Department of Medicine, University of Alabama, Birmingham, AL, USA, 18Infectious Diseases Program, Corporació Sanitària Parc Taulí, Sabadell, Barcelona, Spain, 19Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid, Spain, 20Research Department of Infection and Population Health, UCL Medical School, London, UK, 21HIV Atlanta VA Cohort Study (HAVACS), Atlanta Veterans Affairs Medical Center, Decatur, GA, USA, 22University of Washington School of Medicine, Seattle, WA, USA, 23Clinic of Infectious Diseases and Tropical Medicine, San Paolo Hospital, University of Milan, Italy and 24First Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany
- Lampe, Fiona. School of Social and Community Medicine, University of Bristol, Bristol, UK, 2Division of Epidemiology and Population Health, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada, 3Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada, 4Center for Interdisciplinary Research on AIDS, Yale University School of Medicine, New Haven, CT, USA, 5VA Connecticut Healthcare System, West Haven, CT, USA, 6Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, TN, USA, 7INSERM, U943, F-75013 Paris, France, 8UPMC University Paris 06, UMR S943, F-75013 Paris, France, 9AP-HP, Groupe hospitalier Pitié-Salpêtrière, Service de Maladies Infectieuses et Tropicales, F-75013 Paris, France, 10Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Switzerland, 11University Bordeaux, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, F-33000 Bordeaux, France, 12INSERM, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, F-33000 Bordeaux, France, 13Division of Infectious Diseases, University of Calgary, Calgary, Canada, 14Copenhagen HIV Programme, Panum Institute, University of Copenhagen, Denmark, 15Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark, 16Stichting HIV Monitoring, Amsterdam, The Netherlands, 17Division of Infectious Disease, Department of Medicine, University of Alabama, Birmingham, AL, USA, 18Infectious Diseases Program, Corporació Sanitària Parc Taulí, Sabadell, Barcelona, Spain, 19Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid, Spain, 20Research Department of Infection and Population Health, UCL Medical School, London, UK, 21HIV Atlanta VA Cohort Study (HAVACS), Atlanta Veterans Affairs Medical Center, Decatur, GA, USA, 22University of Washington School of Medicine, Seattle, WA, USA, 23Clinic of Infectious Diseases and Tropical Medicine, San Paolo Hospital, University of Milan, Italy and 24First Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany
- Ingle, Suzanne. School of Social and Community Medicine, University of Bristol, Bristol, UK, 2Division of Epidemiology and Population Health, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada, 3Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada, 4Center for Interdisciplinary Research on AIDS, Yale University School of Medicine, New Haven, CT, USA, 5VA Connecticut Healthcare System, West Haven, CT, USA, 6Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, TN, USA, 7INSERM, U943, F-75013 Paris, France, 8UPMC University Paris 06, UMR S943, F-75013 Paris, France, 9AP-HP, Groupe hospitalier Pitié-Salpêtrière, Service de Maladies Infectieuses et Tropicales, F-75013 Paris, France, 10Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Switzerland, 11University Bordeaux, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, F-33000 Bordeaux, France, 12INSERM, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, F-33000 Bordeaux, France, 13Division of Infectious Diseases, University of Calgary, Calgary, Canada, 14Copenhagen HIV Programme, Panum Institute, University of Copenhagen, Denmark, 15Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark, 16Stichting HIV Monitoring, Amsterdam, The Netherlands, 17Division of Infectious Disease, Department of Medicine, University of Alabama, Birmingham, AL, USA, 18Infectious Diseases Program, Corporació Sanitària Parc Taulí, Sabadell, Barcelona, Spain, 19Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid, Spain, 20Research Department of Infection and Population Health, UCL Medical School, London, UK, 21HIV Atlanta VA Cohort Study (HAVACS), Atlanta Veterans Affairs Medical Center, Decatur, GA, USA, 22University of Washington School of Medicine, Seattle, WA, USA, 23Clinic of Infectious Diseases and Tropical Medicine, San Paolo Hospital, University of Milan, Italy and 24First Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany
- Guest, Jodie L.. School of Social and Community Medicine, University of Bristol, Bristol, UK, 2Division of Epidemiology and Population Health, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada, 3Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada, 4Center for Interdisciplinary Research on AIDS, Yale University School of Medicine, New Haven, CT, USA, 5VA Connecticut Healthcare System, West Haven, CT, USA, 6Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, TN, USA, 7INSERM, U943, F-75013 Paris, France, 8UPMC University Paris 06, UMR S943, F-75013 Paris, France, 9AP-HP, Groupe hospitalier Pitié-Salpêtrière, Service de Maladies Infectieuses et Tropicales, F-75013 Paris, France, 10Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Switzerland, 11University Bordeaux, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, F-33000 Bordeaux, France, 12INSERM, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, F-33000 Bordeaux, France, 13Division of Infectious Diseases, University of Calgary, Calgary, Canada, 14Copenhagen HIV Programme, Panum Institute, University of Copenhagen, Denmark, 15Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark, 16Stichting HIV Monitoring, Amsterdam, The Netherlands, 17Division of Infectious Disease, Department of Medicine, University of Alabama, Birmingham, AL, USA, 18Infectious Diseases Program, Corporació Sanitària Parc Taulí, Sabadell, Barcelona, Spain, 19Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid, Spain, 20Research Department of Infection and Population Health, UCL Medical School, London, UK, 21HIV Atlanta VA Cohort Study (HAVACS), Atlanta Veterans Affairs Medical Center, Decatur, GA, USA, 22University of Washington School of Medicine, Seattle, WA, USA, 23Clinic of Infectious Diseases and Tropical Medicine, San Paolo Hospital, University of Milan, Italy and 24First Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany
- Crane, Heidi M.. School of Social and Community Medicine, University of Bristol, Bristol, UK, 2Division of Epidemiology and Population Health, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada, 3Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada, 4Center for Interdisciplinary Research on AIDS, Yale University School of Medicine, New Haven, CT, USA, 5VA Connecticut Healthcare System, West Haven, CT, USA, 6Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, TN, USA, 7INSERM, U943, F-75013 Paris, France, 8UPMC University Paris 06, UMR S943, F-75013 Paris, France, 9AP-HP, Groupe hospitalier Pitié-Salpêtrière, Service de Maladies Infectieuses et Tropicales, F-75013 Paris, France, 10Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Switzerland, 11University Bordeaux, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, F-33000 Bordeaux, France, 12INSERM, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, F-33000 Bordeaux, France, 13Division of Infectious Diseases, University of Calgary, Calgary, Canada, 14Copenhagen HIV Programme, Panum Institute, University of Copenhagen, Denmark, 15Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark, 16Stichting HIV Monitoring, Amsterdam, The Netherlands, 17Division of Infectious Disease, Department of Medicine, University of Alabama, Birmingham, AL, USA, 18Infectious Diseases Program, Corporació Sanitària Parc Taulí, Sabadell, Barcelona, Spain, 19Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid, Spain, 20Research Department of Infection and Population Health, UCL Medical School, London, UK, 21HIV Atlanta VA Cohort Study (HAVACS), Atlanta Veterans Affairs Medical Center, Decatur, GA, USA, 22University of Washington School of Medicine, Seattle, WA, USA, 23Clinic of Infectious Diseases and Tropical Medicine, San Paolo Hospital, University of Milan, Italy and 24First Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany
- D'Arminio Monforte, Antonella. School of Social and Community Medicine, University of Bristol, Bristol, UK, 2Division of Epidemiology and Population Health, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada, 3Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada, 4Center for Interdisciplinary Research on AIDS, Yale University School of Medicine, New Haven, CT, USA, 5VA Connecticut Healthcare System, West Haven, CT, USA, 6Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, TN, USA, 7INSERM, U943, F-75013 Paris, France, 8UPMC University Paris 06, UMR S943, F-75013 Paris, France, 9AP-HP, Groupe hospitalier Pitié-Salpêtrière, Service de Maladies Infectieuses et Tropicales, F-75013 Paris, France, 10Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Switzerland, 11University Bordeaux, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, F-33000 Bordeaux, France, 12INSERM, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, F-33000 Bordeaux, France, 13Division of Infectious Diseases, University of Calgary, Calgary, Canada, 14Copenhagen HIV Programme, Panum Institute, University of Copenhagen, Denmark, 15Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark, 16Stichting HIV Monitoring, Amsterdam, The Netherlands, 17Division of Infectious Disease, Department of Medicine, University of Alabama, Birmingham, AL, USA, 18Infectious Diseases Program, Corporació Sanitària Parc Taulí, Sabadell, Barcelona, Spain, 19Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid, Spain, 20Research Department of Infection and Population Health, UCL Medical School, London, UK, 21HIV Atlanta VA Cohort Study (HAVACS), Atlanta Veterans Affairs Medical Center, Decatur, GA, USA, 22University of Washington School of Medicine, Seattle, WA, USA, 23Clinic of Infectious Diseases and Tropical Medicine, San Paolo Hospital, University of Milan, Italy and 24First Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany
- Vehreschild, Jörg J.. School of Social and Community Medicine, University of Bristol, Bristol, UK, 2Division of Epidemiology and Population Health, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada, 3Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada, 4Center for Interdisciplinary Research on AIDS, Yale University School of Medicine, New Haven, CT, USA, 5VA Connecticut Healthcare System, West Haven, CT, USA, 6Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, TN, USA, 7INSERM, U943, F-75013 Paris, France, 8UPMC University Paris 06, UMR S943, F-75013 Paris, France, 9AP-HP, Groupe hospitalier Pitié-Salpêtrière, Service de Maladies Infectieuses et Tropicales, F-75013 Paris, France, 10Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Switzerland, 11University Bordeaux, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, F-33000 Bordeaux, France, 12INSERM, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, F-33000 Bordeaux, France, 13Division of Infectious Diseases, University of Calgary, Calgary, Canada, 14Copenhagen HIV Programme, Panum Institute, University of Copenhagen, Denmark, 15Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark, 16Stichting HIV Monitoring, Amsterdam, The Netherlands, 17Division of Infectious Disease, Department of Medicine, University of Alabama, Birmingham, AL, USA, 18Infectious Diseases Program, Corporació Sanitària Parc Taulí, Sabadell, Barcelona, Spain, 19Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid, Spain, 20Research Department of Infection and Population Health, UCL Medical School, London, UK, 21HIV Atlanta VA Cohort Study (HAVACS), Atlanta Veterans Affairs Medical Center, Decatur, GA, USA, 22University of Washington School of Medicine, Seattle, WA, USA, 23Clinic of Infectious Diseases and Tropical Medicine, San Paolo Hospital, University of Milan, Italy and 24First Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany
- Sterne, Jonathan AC. School of Social and Community Medicine, University of Bristol, Bristol, UK, 2Division of Epidemiology and Population Health, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada, 3Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada, 4Center for Interdisciplinary Research on AIDS, Yale University School of Medicine, New Haven, CT, USA, 5VA Connecticut Healthcare System, West Haven, CT, USA, 6Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, TN, USA, 7INSERM, U943, F-75013 Paris, France, 8UPMC University Paris 06, UMR S943, F-75013 Paris, France, 9AP-HP, Groupe hospitalier Pitié-Salpêtrière, Service de Maladies Infectieuses et Tropicales, F-75013 Paris, France, 10Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Switzerland, 11University Bordeaux, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, F-33000 Bordeaux, France, 12INSERM, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, F-33000 Bordeaux, France, 13Division of Infectious Diseases, University of Calgary, Calgary, Canada, 14Copenhagen HIV Programme, Panum Institute, University of Copenhagen, Denmark, 15Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark, 16Stichting HIV Monitoring, Amsterdam, The Netherlands, 17Division of Infectious Disease, Department of Medicine, University of Alabama, Birmingham, AL, USA, 18Infectious Diseases Program, Corporació Sanitària Parc Taulí, Sabadell, Barcelona, Spain, 19Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid, Spain, 20Research Department of Infection and Population Health, UCL Medical School, London, UK, 21HIV Atlanta VA Cohort Study (HAVACS), Atlanta Veterans Affairs Medical Center, Decatur, GA, USA, 22University of Washington School of Medicine, Seattle, WA, USA, 23Clinic of Infectious Diseases and Tropical Medicine, San Paolo Hospital, University of Milan, Italy and 24First Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany
- Type de document
-
- Postprint
- Langue
-
- Inglese
- Publié dans
-
- International Journal of Epidemiology, 2012, vol. 41, no. 6, p. 1807-1820. Oxford University Press
- Autre version électronique
-
- Publisher's version : https://doi.org/10.1093/ije/dys164
- Classification
-
- Santé
- Mots clés
- Identifiant OAI-PMH
-
- oai:doc.rero.ch:299149
- Summary
- Background HIV cohort collaborations, which pool data from diverse patient cohorts, have provided key insights into outcomes of antiretroviral therapy (ART). However, the extent of, and reasons for, between-cohort heterogeneity in rates of AIDS and mortality are unclear. Methods We obtained data on adult HIV-positive patients who started ART from 1998 without a previous AIDS diagnosis from 17 cohorts in North America and Europe. Patients were followed up from 1 month to 2 years after starting ART. We examined between-cohort heterogeneity in crude and adjusted (age, sex, HIV transmission risk, year, CD4 count and HIV-1 RNA at start of ART) rates of AIDS and mortality using random-effects meta-analysis and meta-regression. Results During 61 520 person-years, 754/38 706 (1.9%) patients died and 1890 (4.9%) progressed to AIDS. Between-cohort variance in mortality rates was reduced from 0.84 to 0.24 (0.73 to 0.28 for AIDS rates) after adjustment for patient characteristics. Adjusted mortality rates were inversely associated with cohorts' estimated completeness of death ascertainment [excellent: 96-100%, good: 90-95%, average: 75-89%; mortality rate ratio 0.66 (95% confidence interval 0.46-0.94) per category]. Mortality rate ratios comparing Europe with North America were 0.42 (0.31-0.57) before and 0.47 (0.30-0.73) after adjusting for completeness of ascertainment. Conclusions Heterogeneity between settings in outcomes of HIV treatment has implications for collaborative analyses, policy and clinical care. Estimated mortality rates may require adjustment for completeness of ascertainment. Higher mortality rate in North American, compared with European, cohorts was not fully explained by completeness of ascertainment and may be because of the inclusion of more socially marginalized patients with higher mortality risk